Condition: Glaucoma Patients · Retina Patients · Eyes With Corneal Abnormality · Sponsor: Intalight, Inc
This study will evaluate the clinical performance of a new swept-source OCT imaging device, the VG200D, and to evaluate substantial equivalence with a predicate device, the Cirrus 5000. Clinical performance will be assessed through an agreement and precision analysis of OCT measurement parameters.
This description comes directly from the study's public registry record.
Mike Sinai, PhD · 6198067636 · mike.sinai@intalight.com
Always discuss trial participation with your own doctor first.
| Illinois College of Optometry | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07355491